Zhou Lihan, a prominent life sciences scholar, has steered Singapore’s Mirxes to a groundbreaking achievement. As the CEO and co-founder of Mirxes, Zhou led the first Southeast Asian biotech start-up to surpass a valuation of over US$1 billion (S$1.29 billion). This milestone was attained on May 23 when Mirxes unveiled its initial public offering (IPO) on the Hong Kong Stock Exchange (HKEX).
Read more from straitstimes.com
